查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771629

花生過敏治療市場規模、佔有率、趨勢分析報告：按藥物類別、給藥途徑、分銷管道、地區、細分市場預測，2025-2033

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine, Immunotherapies), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

花生過敏治療市場的成長與趨勢：

根據 Grand View Research 的一份新報告，全球花生過敏治療市場預計到 2033 年將達到 14.615 億美元。

預計 2025 年至 2033 年期間市場複合年成長率為 11.43%。推動市場成長的關鍵因素包括強大的產品平臺、高疾病盛行率、藥物輸送系統的進步以及主要企業的策略性舉措。

主要市場參與企業正在透過各種策略強化其花生過敏治療產品線。例如，Aravax 於 2022 年 12 月啟動 B 輪資金籌措，獲得澳洲知名醫療保健企業家 Tenmile 和 Brandon Capital 的 2,000 萬美元投資。這筆資金籌措將使 Aravax 能夠啟動 PVX108 針對花生過敏患者的 II 期臨床試驗。預計這筆資金籌措將用於推進研發項目。

越來越多的花生過敏治療藥物核准也刺激了市場發展。 2020年1月，美國食品藥物管理局(FDA) 批准了由Aimmune Therapeutics, Inc. 開發的PALFORZIA [花生（Arachis hypogaea）過敏原粉-dnfp]。 PALFORZIA是第一個核准花生過敏患者的免疫療法。該藥物是一種口服免疫療法，旨在減少因攝入花生引起的過敏反應，包括過敏性休克。該藥物適用於已確診過敏的患者，建議4至17歲兒童增加初始劑量。

截至2023年第一季，多款前景研發線產品正在臨床開發中，包括DBV Technologies的Viaskin Peanut、Dupixient的CA002以及賽諾菲與再生元合作的Camallegr。此外，ADP101、VE416、INP20和CNP-201等產品也正在開發中。預計這些藥物的引入將有助於預測期內市場的成長和擴張。

花生過敏治療市場報告重點

  • 2024 年，腎上腺素領域佔據了主要市場佔有率。過敏反應治療的標準是腎上腺素自動注射器，這對緊急過敏管理也至關重要。
  • 根據給藥途徑，注射劑預計將在 2024 年佔據市場主導地位，這是因為人們越來越重視以患者為中心的護理，這推動了實用、痛苦較小且患者更易於使用的注射療法的發展，包括探索注射療法的替代輸送系統，如穿戴式技術和自動注射器。
  • 按分銷管道分類，醫院藥房在 2024 年佔據了最大的市場佔有率。醫院藥房專注於為花生過敏患者提供支援和資訊。
  • 北美在這個市場上佔據著強勢地位，因為這裡擁有許多製藥公司、學術機構和研究機構，這些公司、學術機構和研究機構目前正在研究新的治療策略來解決花生過敏的根本原因，包括基因療法、生技藥品和其他免疫調節干預措施。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 花生過敏治療市場變數、趨勢與範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTLE分析
    • 管道分析
    • 專利到期分析
    • 定價分析

4. 花生過敏治療市場-藥物類業務分析

  • 2024 年及 2033 年藥品類別市場佔有率
  • 藥品類別細分儀表板
  • 2021 年至 2033 年按藥物類別分類的市場規模、預測與趨勢分析
  • 抗組織胺藥
  • 腎上腺素
  • 免疫療法
  • 其他

5. 花生過敏治療市場：給藥途徑業務分析

  • 2024年及2033年給藥途徑市場佔有率
  • 給藥途徑細分儀表板
  • 2021 年至 2033 年按藥物類別分類的市場規模、預測與趨勢分析
  • 口服
  • 注射
  • 其他

6. 花生過敏治療市場：通路業務分析

  • 2024年及2033年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 按分銷管道分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 醫院藥房
  • 零售藥局
  • 其他

7. 花生過敏治療市場：區域估計與趨勢分析

  • 2024 年及 2033 年區域市場佔有率分析
  • 區域市場儀表板
  • 2021-2033年市場規模與預測趨勢分析
  • 北美洲
    • 按國家/地區，2021-2033 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Aimmune Therapeutics（Nestle Health Science）
    • DBV Technologies
    • Sanofi
    • ALK-Abello
    • Prota Therapeutics
    • Camallergy
    • Aravax
    • Arch Pharmalabs
    • Genentech
Product Code: GVR-4-68040-097-6

Peanut Allergy Treatment Market Growth & Trends:

The global peanut allergy treatment market size is expected to reach USD 1,461.5 million by 2033, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 11.43% from 2025 to 2033. Some of the key factors propelling the market growth include a robust product pipeline, high disease prevalence, advancement in the drug delivery system, and strategic initiatives by key players.

Key market players are bolstering their pipeline for peanut allergy treatment through various strategies. For instance, Aravax initiated its series B funding round in December 2022, securing a USD 20 million investment from renowned Australian healthcare entrepreneurs Tenmile and Brandon Capital. This financing will enable Aravax to commence phase II clinical trials of PVX108, targeting individuals who experience allergic reactions to peanuts. Such fundings are expected to drive advancements in research and development programs.

The market is stimulated by the increasing number of product approvals for peanut allergy treatment. In January 2020, the U.S. Food and Drug Administration (FDA) granted authorization to PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp], developed by Aimmune Therapeutics, Inc. PALFORZIA is the first immunotherapy medication approved for individuals with peanut allergies. It is an oral immune therapy designed to reduce allergy responses, including anaphylaxis triggered by accidental peanut ingestion. It is intended for individuals who have a confirmed allergy, with initial dose escalation recommended for children aged four to 17.

As of the first quarter of 2023, several promising pipeline products are undergoing clinical development. These include Viaskin Peanut by DBV Technologies, CA002 by Dupixient, and Camallegr, a collaborative effort between Sanofi and Regeneron. Additionally, other assets such as ADP101, VE416, INP20, and CNP-201 are also in development. The introduction of these medications is anticipated to contribute to the growth and expansion of the market during the projected forecast period.

Peanut Allergy Treatment Market Report Highlights:

  • The epinephrine segment held the major market share in 2024. The standard of care for anaphylaxis treatment has been epinephrine auto-injectors, which are also essential in the management of allergies in emergency situations.
  • By route of administration, the injectable segment dominated the market in 2024 owing to the development of injectable treatments that are practical, less painful, and easier to use for patients is being pursued in response to the growing emphasis on patient-centered care. This includes looking at alternative delivery systems for injectable therapies, such as wearable technology or auto-injectors.
  • By distribution channel, the hospital pharmacy segment held the largest market share in 2024. Hospital pharmacies put more of an emphasis on offering patient support and information for people with peanut allergies.
  • North America has established a strong regional position in the market. This is due to the presence of numerous pharmaceutical companies, academic institutions, and research organizations currently looking into new therapeutic strategies to address the underlying causes of peanut allergies, including gene therapy, biologics, and other immunomodulatory interventions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Route of Administration
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Peanut Allergy Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Peanut Allergy Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2033
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 4.4. Antihistamines
    • 4.4.1. Antihistamines Market, 2021 - 2033 (USD Million)
  • 4.5. Epinephrine
    • 4.5.1. Epinephrine Market, 2021 - 2033 (USD Million)
  • 4.6. Immunotherapies
    • 4.6.1. Immunotherapies Market, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Peanut Allergy Treatment Market: Route of Administration Business Analysis

  • 5.1. Route of Administration Market Share, 2024 & 2033
  • 5.2. Route of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market, 2021 - 2033 (USD Million)
  • 5.5. Injectable
    • 5.5.1. Injectable Market, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Peanut Allergy Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2033
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Peanut Allergy Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Peanut Allergy Treatment Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. U.S. Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. Uk Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Japan Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. China Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Peanut Allergy Treatment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Aimmune Therapeutics (Nestle Health Science)
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. DBV Technologies
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Sanofi
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. ALK-Abello
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Prota Therapeutics
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Camallergy
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Aravax
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Arch Pharmalabs
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Genentech
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Peanut Allergy Treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 5 Global Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 6 North America Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 8 North America Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 9 U.S. Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 10 U.S. Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11 Canada Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 12 Canada Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 13 Mexico Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 14 Mexico Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15 Europe Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 16 Europe Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 17 Europe Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 UK Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 19 UK Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20 Germany Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 21 Germany Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22 France Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 23 France Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24 Italy Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 25 Italy Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 Spain Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 27 Spain Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28 Norway Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 29 Norway Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30 Denmark Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 31 Denmark Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Sweden Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 33 Sweden Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 37 Japan Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 38 Japan Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 39 China Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 40 China Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 41 India Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 42 India Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 43 Australia Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 44 Australia Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 45 South Korea Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 46 South Korea Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 47 Thailand Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 48 Thailand Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 49 Latin America Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 50 Latin America Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 51 Latin America Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 52 Brazil Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 53 Brazil Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 Argentina Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 55 Argentina Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 59 South Africa Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 60 South Africa Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 63 UAE Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 64 UAE Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 65 Kuwait Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 66 Kuwait Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Peanut Allergy Treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Peanut Allergy Treatment market dynamics
  • Fig. 12 Peanut Allergy Treatment market: Porter's five forces analysis
  • Fig. 13 Peanut Allergy Treatment market: PESTLE analysis
  • Fig. 14 Drug Class market, 2021 - 2033 (USD Million)
  • Fig. 15 Antihistamines market, 2021 - 2033 (USD Million)
  • Fig. 16 Epinephrine market, 2021 - 2033 (USD Million)
  • Fig. 17 Immunotherapies market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 Route of Administration market, 2021 - 2033 (USD Million)
  • Fig. 20 Oral market, 2021 - 2033 (USD Million)
  • Fig. 21 Injectable market, 2021 - 2033 (USD Million)
  • Fig. 22 Others market, 2021 - 2033 (USD Million)
  • Fig. 23 Distribution Channel market, 2021 - 2033 (USD Million)
  • Fig. 24 Hospital Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 25 Retail Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 26 Others market, 2021 - 2033 (USD Million)
  • Fig. 27 Peanut Allergy Treatment market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 MEA Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework